Chinese pharmaceutical company Yifan Pharmaceutical Co., Ltd. (Yifan Pharmaceutical, 002019.SZ) has recently announced that its subsidiary Evive Biotechnology Inc. (Evive) signed an exclusive license agreement with Acrotech Biopharma Inc. (Acrotech) for the sales of F-627, an injection product under research by Evive, in the United States.

November18,2022

The German pharmaceutical company Merz has invested around 40 million euros in its site in Dessau-Rosslau, in the eastern German state of Saxony-Anhalt.

September09,2022

Sirio Pharma Co., Ltd. (300791.SZ), a Chinese leading integrated contract manufacturer for the dietary supplement industry, on Thursday announced share issuance plan with the raised funds to buy 80 percent stake in Best Formulations Inc, a U.S. nutraceutical and pharmaceutical company.

July08,2022

Chinese pharmaceutical company Huadong Medicine Co.,Ltd. (Huadong Medicine, 000963.SZ) has forged a strategic partnership with German-based biopharmaceutical firm Heidelberg Pharma AG (Heidelberg Pharma) with the signing of an equity investment agreement and an exclusive licensing agreement, according to Huadong Medicine's filing to the Shenzhen Stock Exchange on Monday.

February28,2022

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. will spend up to 250 million yuan (36 million U.S. dollars) to buy GlaxoSmithKline's Suzhou pharmaceutical factory in east China, according to a Fosun statement released Tuesday.

July10,2019

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SH) announced Friday that its abbreviated new drug application (ANDA) for 50mg doxycycline hydrochloride sustained-release tablets had gotten the approval of the U.S. Food and Drug Administration (FDA ).

February22,2019

Chinese authorities have penalized Changchun Changsheng Life Sciences Limited and its executives over illegalities related to making defective human rabies vaccine.

December12,2018

The Shanghai municipal government has rolled out an action plan to promote high-quality development of bio-pharmaceutical industry from 2018-2020, Shanghai Securities News reported on Wednesday.

December06,2018

Chinese pharmaceutical companies boosted their exports to the United States at an exhibition in Las Vegas on Thursday and Friday, with an actual transaction of more than 2.3 million dollars.

November12,2018

Tasly Pharmaceutical Group CO.,LTD (600535.SH) announced that it had inked investment agreement and product development commercialization agreement with Mesoblast, the world's leading stem cell R&D company.

July18,2018

Chinese pharmaceutical company WuXi Biologics will invest 325 million euros (393 million U.S. dollars) in a new manufacturing facility in Dundalk, Ireland, the firm announced on Monday.

May03,2018

Harbin Pharmaceutical Group Holding Co Ltd, better known as Hayao, said it will invest about 300 million U.S. dollars in GNC Holdings Inc, potentially becoming the single largest shareholder in the US company with a 40-percent stake.

February26,2018

Ethiopia will commission Chinese-built Kilinto industrial park which will host pharmaceutical companies in March 2018, an Ethiopian official said on December 24.

December25,2017

Chinese lawmakers have called for more administrative support for the country's pharmaceutical industry to boost the development of new drugs.

June27,2017